These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8500426)

  • 1. [The therapy and prevention of gastroduodenal lesions].
    Rösch W
    Dtsch Med Wochenschr; 1993 May; 118(20):764. PubMed ID: 8500426
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
    Gisbert JP; Boixeda D; Martín de Argila C
    Rev Esp Enferm Dig; 1997 Feb; 89(2):116-23. PubMed ID: 9115818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems in the traditional pharmacotherapy and prevention of peptic ulcer].
    Ryss ES
    Ter Arkh; 1984; 56(9):106-10. PubMed ID: 6393409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibilities, problems and limits of the conservative acute therapy and long-term prevention of gastroduodenal ulcer disease].
    Hotz J
    Med Klin (Munich); 1986 May; 81(10):357-64. PubMed ID: 3097468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current problems in the treatment of gastroduodenal ulcer].
    Dumitraşcu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(5):401-11. PubMed ID: 2881332
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lansoprazole: an analysis of the clinical trials in the 3 years of 1997-1999].
    Dobrilla G; Capurso L
    Recenti Prog Med; 2000 Apr; 91(4):191-210. PubMed ID: 10804753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endoscopic follow-up of recurrences of gastroduodenal ulcer after treatment with Ulcosilvanil (4-year study)].
    Puşcaş I; Buzáş G; Voicu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(4):357-9. PubMed ID: 6140734
    [No Abstract]   [Full Text] [Related]  

  • 11. Helicobacter pylori infection.
    Delaney B; Moayyedi P; Forman D
    Clin Evid; 2002 Jun; (7):414-28. PubMed ID: 12230667
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical aspects and therapy: gastroduodenal ulcer].
    Rösch W
    Krankenpfl J; 1983; 21():19-21. PubMed ID: 6550665
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticholinergics and cytoprotectants in gastroduodenal ulcer].
    Bernardi P; Fidanza F; Mancini L; Pace V
    Riv Eur Sci Med Farmacol; 1993; 15(2):99-105. PubMed ID: 8171220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prevention of gastroduodenal ulcer: what is the evidence?].
    Pfaender S; Perrier A; Nendaz M
    Rev Med Suisse; 2006 Oct; 2(83):2337-8, 2340, 2342-3. PubMed ID: 17112084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 17. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
    Søndergaard B; Bytzer P
    Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
    [No Abstract]   [Full Text] [Related]  

  • 19. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
    Tsuji S; Kawano S
    J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
    [No Abstract]   [Full Text] [Related]  

  • 20. Use new diagnostic know-how to improve prevention, treatment of peptic ulcer disease.
    Healthc Demand Dis Manag; 1997 Oct; 3(10):154-5. PubMed ID: 10176754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.